A thriving multi-kingdom microbial ecosystem inhabits the respiratory tract: the respiratory
tract microbiome (RTM). In recent years, the contribution of the RTM to human health has …

The growing crisis of antibiotic resistance calls for advanced and sustainable antibacterial
strategies. In the past few years, lanthanide‐doped upconversion nanoparticles (UCNPs) …

In a healthcare setting, biofilms are a major source of infection and difficult to eradicate once
formed. Nanoparticles (NPs) can be designed to effectively penetrate biofilms to more …

Gold nanoparticles (AuNPs) have been proven to be a remarkable choice for utilization as
an antibacterial agent. AuNP has been demonstrated to have a satisfactory performance …

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis that
replicates inside human alveolar macrophages. This disease causes significant morbidity …

The nasal cavity is a primary checkpoint for the invasion of respiratory pathogens. Numerous
pathogens, including SARS-CoV-2, S. pneumoniae, S. aureus, etc., can adhere/colonize …

People with cystic fibrosis (CF) suffer from recurrent bacterial infections which induce
inflammation, lung tissue damage and failure of the respiratory system. Prolonged exposure …

The chemical compositions, structures, and electrokinetic potentials have been studied for
silver-containing Janus-type ZnO/Ag nanoparticles, heterophase Cu/Ag nanoparticles with a …

The escalating prevalence of lung diseases underscores the need for innovative therapies.
Dysbiosis in human body microbiome has emerged as a significant factor in these diseases …

Cancer remains a formidable global health challenge, underscoring the critical need for
early and accurate diagnostic tools. In recent years, nanotechnology has emerged as a …